News

Forbion closes third life sciences fund, FCF III, raising over $200m

April 12, 2016

Human Health

Company

Back

Download

PDF

Forbion Capital Partners (“Forbion”), a dedicated life sciences venture capital firm, today announced the final closing of its third main fund Forbion Capital Fund III (FCF III), raising a total of EUR 183 million (approx. USD 208 million).